HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
André J Olthaar Selected Research
André J Olthaar Research Topics
Disease
3
Insulin Resistance
10/2004 - 11/2002
2
Hyperglycemia
10/2004 - 11/2002
2
Type 2 Diabetes Mellitus (MODY)
10/2004 - 11/2002
1
Thyroid Diseases (Thyroid Disease)
01/2023
1
Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2022
1
Galactosemias (Galactosemia)
04/2011
1
Congenital Disorders of Glycosylation
04/2011
1
Ovarian Epithelial Carcinoma
05/2008
1
Ovarian Neoplasms (Ovarian Cancer)
05/2008
1
Hyperlipidemias (Hyperlipidemia)
10/2004
Drug/Important Bio-Agent (IBA)
3
Hexosamines
IBA
10/2004 - 11/2002
3
Uridine Diphosphate (UDP)
IBA
10/2004 - 11/2002
2
Acetylglucosamine
IBA
10/2004 - 11/2002
2
Uridine Diphosphate Galactose (UDP Galactose)
IBA
10/2004 - 11/2002
2
Insulin (Novolin)
FDA Link
10/2004 - 11/2002
2
Uridine Diphosphate Glucose (UDP Glucose)
IBA
10/2004 - 11/2002
2
Glucose (Dextrose)
FDA Link
Generic
02/2004 - 11/2002
1
Thyroxine (Levothyroxine)
FDA Link
Generic
01/2023
1
17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)
IBA
01/2022
1
Glucocorticoids
IBA
01/2022
1
Androstenedione (4 Androstene 3,17 dione)
IBA
01/2022
1
phosphomannomutase
IBA
04/2011
1
Congenital disorder of glycosylation type 1A
IBA
04/2011
1
Protein Isoforms (Isoforms)
IBA
04/2011
1
Antibodies
IBA
05/2008
1
Monoclonal Antibodies
IBA
05/2008
1
Hexoses
IBA
10/2004
1
Acetylgalactosamine
IBA
10/2004
1
Leptin
IBA
10/2004
1
Uridine Diphosphate N-Acetylgalactosamine
IBA
11/2002
Therapy/Procedure
1
Therapeutics
05/2008